title: Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
authors.forename: B
authors.initials: B
authors.lastname: Desablens
authors.forename: P
authors.initials: P
authors.lastname: Fievet
authors.forename: A
authors.initials: A
authors.lastname: Pruna
authors.forename: J F
authors.initials: JF
authors.lastname: Claisse
authors.forename: P F
authors.initials: PF
authors.lastname: Westeel
authors.forename: M
authors.initials: M
authors.lastname: Tolani
authors.forename: A
authors.initials: A
authors.lastname: Fournier
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D008545:Melanoma / Q000150:complications / Q000628:therapy; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy; D065227:Transfusion Reaction
chemical_list: D008937:Mitomycins; D016685:Mitomycin